Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer

TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation and or …
Jetzt den vollständigen Artikel lesen